ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in ARS Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +3 vs. Q3 2023
- Shares held
- 65.4M
- −1.11M (−1.7%) vs. Q3 2023
- Total value
- $358.5M
- +$107.0M (+42.5%) vs. Q3 2023
- New holders
- 19
- 30 more added
- Sold out
- 16
- 29 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SPRY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $726.0M |
| Q1 2026 | 203 | $757.5M |
| Q4 2025 | 191 | $1.05B |
| Q3 2025 | 188 | $840.4M |
| Q2 2025 | 188 | $1.48B |
| Q1 2025 | 184 | $958.9M |
| Q4 2024 | 166 | $752.3M |
| Q3 2024 | 151 | $928.4M |
| Q2 2024 | 115 | $533.0M |
| Q1 2024 | 113 | $612.1M |
| Q4 2023 | 100 | $358.5M |
| Q3 2023 | 97 | $251.6M |
| Q2 2023 | 92 | $369.0M |
| Q1 2023 | 90 | $347.7M |
| Q4 2022 | 73 | $427.9M |
| Q3 2022 | 61 | $160.4M |
| Q2 2022 | 64 | $110.5M |
| Q1 2022 | 70 | $94.7M |
| Q4 2021 | 72 | $200.5M |
| Q3 2021 | 74 | $288.4M |
| Q2 2021 | 76 | $864.6M |
| Q1 2021 | 68 | $1.21B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding ARS Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 0 | $0 | 0.00% | −1,097,525−100.0% | Sold out |
| Clearline Capital LP | 0 | $0 | 0.00% | −271,678−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −260,684−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −80,816−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −13,835−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −11,280−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −10,760−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −10,794−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,371−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,117−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −10,042−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −6,143−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −707−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −151−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |